Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection.
A. Vianello (Padova (PD), Italy), F. Braccioni (Padova (PD), Italy), G. Guarnieri (Padova (PD), Italy), B. Molena (Padova (PD), Italy), A. Achille (Padova (PD), Italy), S. Lococo (Padova (PD), Italy), L. Salviati (Padova (PD), Italy), E. Crisafulli (Verona (VR), Italy), L. Bertagna De Marchi (Padova (PD), Italy), M. Caminati (Verona (VR), Italy), G. Senna (Verona (VR), Italy)
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Vianello (Padova (PD), Italy), F. Braccioni (Padova (PD), Italy), G. Guarnieri (Padova (PD), Italy), B. Molena (Padova (PD), Italy), A. Achille (Padova (PD), Italy), S. Lococo (Padova (PD), Italy), L. Salviati (Padova (PD), Italy), E. Crisafulli (Verona (VR), Italy), L. Bertagna De Marchi (Padova (PD), Italy), M. Caminati (Verona (VR), Italy), G. Senna (Verona (VR), Italy). Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection.. 812
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: